Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function
<h4>Aims</h4> Impaired renal function is a major contributor to the low proportion of mineralocorticoid receptor antagonist (MRA) treatment in patients with heart failure with reduced ejection fraction (HFrEF). Our aims were to investigate the impact of MRA treatment on all-cause mortali...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Public Library of Science (PLoS)
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/c25bd920c35e463092d0df238e9d68ed |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|